About R. (Ruben) Malmberg
Introduction
Ruben is currently working on his PhD research project on advances in cost-effective oncology care.
Field(s) of expertise
- Oncology.
Education and career
- PharmD.
Publications
- Effect of reducing the paediatric stavudine dose by half: a physiologically-based pharmacokinetic model. PMID: 25697412
- Letter to the editor: Comments on 'A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation'. PMID: 32854077
- Cox, J. M., van Doorn, L., Malmberg, R., Oomen-de Hoop, E., Bosch, T. M., van den Bemt, P. M. L. A. et al. The added value of H2-antagonists in premedication regimens during paclitaxel treatment. Br. J. Cancer (2021)
